{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T16:04:06Z","timestamp":1779638646712,"version":"3.53.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,24]]},"DOI":"10.7759\/cureus.109546","type":"journal-article","created":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T15:31:43Z","timestamp":1779636703000},"source":"Crossref","is-referenced-by-count":0,"title":["Upadacitinib for Severe Refractory Hidradenitis Suppurativa After Failure of Multiple Systemic Therapies: A Case Report"],"prefix":"10.7759","author":[{"given":"Emanuel","family":"Chew Bonilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xurami","family":"Vega-Del Pilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sthephany","family":"Benitez Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Miranda Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Lemini L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)02475-9","article-title":"Hidradenitis suppurativa","volume":"405","author":"Sabat R","year":"2025","unstructured":"Sabat R, Alavi A, Wolk K, et al.. Hidradenitis suppurativa. Lancet. 2025, 405:420-38. 10.1016\/S0140-6736(24)02475-9","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20472","article-title":"European S2k guidelines for hidradenitis suppurativa\/acne inversa part 2: treatment","volume":"39","author":"Zouboulis CC","year":"2025","unstructured":"Zouboulis CC, Bechara FG, Benhadou F, et al.. European S2k guidelines for hidradenitis suppurativa\/acne inversa part 2: treatment. J Eur Acad Dermatol Venereol. 2025, 39:899-941. 10.1111\/jdv.20472","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59040801","article-title":"Hidradenitis suppurativa and JAK inhibitors: a review of the published literature","volume":"59","author":"Martora F","year":"2023","unstructured":"Martora F, Scalvenzi M, Ruggiero A, Potestio L, Battista T, Megna M. Hidradenitis suppurativa and JAK inhibitors: a review of the published literature. Medicina (Kaunas). 2023, 59:801. 10.3390\/medicina59040801","journal-title":"Medicina (Kaunas)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/cells10082094","article-title":"Hidradenitis suppurativa: where we are and where we are going","volume":"10","author":"Scala E","year":"2021","unstructured":"Scala E, Cacciapuoti S, Garzorz-Stark N, et al.. Hidradenitis suppurativa: where we are and where we are going. Cells. 2021, 10:2094. 10.3390\/cells10082094","journal-title":"Cells"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-020-01381-7","article-title":"Transcriptomic analysis of hidradenitis suppurativa skin suggests roles for multiple inflammatory pathways in disease pathogenesis","volume":"69","author":"Rumberger BE","year":"2020","unstructured":"Rumberger BE, Boarder EL, Owens SL, Howell MD. Transcriptomic analysis of hidradenitis suppurativa skin suggests roles for multiple inflammatory pathways in disease pathogenesis. Inflamm Res. 2020, 69:967-73. 10.1007\/s00011-020-01381-7","journal-title":"Inflamm Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljac096","article-title":"Keratinocytes and immune cells in the epidermis are key drivers of inflammation in hidradenitis suppurativa providing a rationale for novel topical therapies","volume":"188","author":"Schell SL","year":"2023","unstructured":"Schell SL, Cong Z, Sennett ML, et al.. Keratinocytes and immune cells in the epidermis are key drivers of inflammation in hidradenitis suppurativa providing a rationale for novel topical therapies. Br J Dermatol. 2023, 188:407-19. 10.1093\/bjd\/ljac096","journal-title":"Br J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.12.046","article-title":"Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: results from a phase 2, randomized, placebo-controlled study","volume":"92","author":"Ackerman LS","year":"2025","unstructured":"Ackerman LS, Schlosser BJ, Zhan T, et al.. Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: results from a phase 2, randomized, placebo-controlled study. J Am Acad Dermatol. 2025, 92:1252-60. 10.1016\/j.jaad.2024.12.046","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15748","article-title":"Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity","volume":"177","author":"Zouboulis CC","year":"2017","unstructured":"Zouboulis CC, Tzellos T, Kyrgidis A, et al.. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol. 2017, 177:1401-9. 10.1111\/bjd.15748","journal-title":"Br J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20969","article-title":"Janus kinase 1 inhibitor INCB054707 for patients with moderate-to-severe hidradenitis suppurativa: results from two phase II studies","volume":"186","author":"Alavi A","year":"2022","unstructured":"Alavi A, Hamzavi I, Brown K, et al.. Janus kinase 1 inhibitor INCB054707 for patients with moderate-to-severe hidradenitis suppurativa: results from two phase II studies. Br J Dermatol. 2022, 186:803-13. 10.1111\/bjd.20969","journal-title":"Br J Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111435","article-title":"A systematic review of Janus kinase inhibitors and spleen tyrosine kinase inhibitors for hidradenitis suppurativa treatment","volume":"127","author":"Heidari A","year":"2024","unstructured":"Heidari A, Ghane Y, Heidari N, Sadeghi S, Goodarzi A. A systematic review of Janus kinase inhibitors and spleen tyrosine kinase inhibitors for hidradenitis suppurativa treatment. Int Immunopharmacol. 2024, 127:111435. 10.1016\/j.intimp.2023.111435","journal-title":"Int Immunopharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.85255","article-title":"A case of refractory hidradenitis suppurativa successfully treated with upadacitinib","volume":"17","author":"Takei I","year":"2025","unstructured":"Takei I, Shibata-Kikuchi S, Honda R, Tokito T, Nakahara T. A case of refractory hidradenitis suppurativa successfully treated with upadacitinib. Cureus. 2025, 17:e85255. 10.7759\/cureus.85255","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-024-03121-x","article-title":"The use of biologics and Jak inhibitors in the management of moderate to severe hidradenitis suppurativa treatment: a scoping review","volume":"316","author":"Guermazi D","year":"2024","unstructured":"Guermazi D, Shah A, Yumeen S, Saliba E. The use of biologics and Jak inhibitors in the management of moderate to severe hidradenitis suppurativa treatment: a scoping review. Arch Dermatol Res. 2024, 316:259. 10.1007\/s00403-024-03121-x","journal-title":"Arch Dermatol Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/495976-upadacitinib-for-severe-refractory-hidradenitis-suppurativa-after-failure-of-multiple-systemic-therapies-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T15:31:44Z","timestamp":1779636704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/495976-upadacitinib-for-severe-refractory-hidradenitis-suppurativa-after-failure-of-multiple-systemic-therapies-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,24]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.109546","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,24]]}}}